Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Exploring OC144-093, a novel P-glycoprotein inhibitor that could transform treatment for pharmacoresistant epilepsy by overcoming the blood-brain barrier.